UK could face opioid crisis of its own, report finds

10 September 2019
addiction_pills_syringe_big

A highly-anticipated  report from Public Health England (PHE) finds that up to a quarter of adults are being prescribed medication for pain, insomnia or depression.

Half of those receiving a prescription had been on the medication continuously for the last year, raising concerns that the UK may face a public health challenge similar to the  opioid crisis experienced by the USA.

The agency, which is tasked with promoting health and well being in England, said that long-term prescribing is “likely to result in dependence or withdrawal problems.”

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical